Disclosures for "Improved Low Contrast Visual Acuity, Reduction in Retinal Ganglion Cell Loss, and Neurofilaments-light with Privosegtor in Acute Optic Neuritis: Results from a Multicenter, Randomized, Placebo-controlled, Double-masked Trial "
-
Dr. Villoslada has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bionure. Dr. Villoslada has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telara Therapeutics. Dr. Villoslada has or had stock in Attune Neurosciences.Dr. Villoslada has or had stock in Bionure Therapeutics.Dr. Villoslada has or had stock in Spiral Therapeutics.Dr. Villoslada has or had stock in Adhera Health.Dr. Villoslada has or had stock in Clarity technologies.Dr. Villoslada has or had stock in QMENTA Inc. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from European Commission. The institution of Dr. Villoslada has received research support from Instituto Salud Carlos III. The institution of Dr. Villoslada has received research support from Focused Ultrasound Foundation and ALS Foundation. The institution of Dr. Villoslada has received research support from Caixa Foundation. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care.
-
Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oculis.
-
Mr. Bonnin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oculis.
-
Dr. Mariani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Oculis. Dr. Mariani has received personal compensation in the range of $0-$499 for serving as a Consultant for Merz. Dr. Mariani has received personal compensation in the range of $0-$499 for serving as a Consultant for Emeis. Dr. Mariani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Paris Brain Institute. Dr. Mariani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Owkin. Dr. Mariani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Elivie. Dr. Mariani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Mariani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DIGITAL MEDICAL HUB. Dr. Mariani has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for John Libbey. The institution of Dr. Mariani has received research support from France Parkinson Association. The institution of Dr. Mariani has received research support from Fondation de France. The institution of Dr. Mariani has received research support from Paris Brain Institute. The institution of Dr. Mariani has received research support from French Ministry of Health. Dr. Mariani has received intellectual property interests from a discovery or technology relating to health care.
-
Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
-
Prof. Froment has nothing to disclose.
-
Dr. Kupersmith has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal firms. Dr. Kupersmith has stock in SafeTherapeutics m,LLC. The institution of Dr. Kupersmith has received research support from NEI, NYEEI FDN, Shulman Family NAION fund. Dr. Kupersmith has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Levin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dompe. Dr. Levin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oculis. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Life Biosciences. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Negev. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perceive. The institution of Dr. Levin has received research support from Canadian Insitutes of Health Research. The institution of Dr. Levin has received research support from CDMRP program of US DoD. Dr. Levin has received publishing royalties from a publication relating to health care.
-
Dr. Markabi has received personal compensation for serving as an employee of Alcon. The institution of Dr. Markabi has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Markabi has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Medincell. Dr. Markabi has received personal compensation in the range of $50,000-$99,999 for serving as a Advisor with Venture Capital firms.
-
Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN . Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE . Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Caroline Papeix has received personal compensation in the range of $0-$499 for serving as a Consultant for NOVARTIS .
-
Prof. TOUITOU has nothing to disclose.
-
Dr. Medori has nothing to disclose.
-
The institution of Prof. Munk has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Oculis. The institution of Prof. Munk has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer. The institution of Prof. Munk has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Isarna . The institution of Prof. Munk has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie.
-
Prof. Zinkernagel has stock in Novartis. Prof. Zinkernagel has a non-compensated relationship as a Board of Directors with EURETINA that is relevant to AAN interests or activities.
-
Prof. Wolf has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oculis. The institution of Prof. Wolf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celltrion. The institution of Prof. Wolf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis.